For help on how to get the results you want, see our search tips.
123 results
Keyword Remove keyword
Medicine
Referrals Remove Referrals filter
-
List item
Referral: Zoloft
sertraline, Article 30 referrals
Status: European Commission final decision, opinion/position date: 18/12/2008, EC decision date: 27/03/2009, Last updated: 07/05/2009 -
List item
Referral: Tazocin
piperacillin, tazobactam, associated names: Tazobac, Tazocel, Tazonam, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/10/2010, EC decision date: 21/02/2011, Last updated: 19/11/2013 -
List item
Referral: Renitec
enalapril, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/09/2002, EC decision date: 21/05/2003, Last updated: 02/12/2003 -
List item
Referral: Calcichew D3 mite
calcium, colecalciferol, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/06/2003, EC decision date: 01/12/2003, Last updated: 21/01/2004 -
List item
Referral: Diovan Comp
valsartan, hydrochlorothiazide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/03/2009, EC decision date: 26/05/2009, Last updated: 11/06/2009 -
List item
Referral: Haldol and associated names
haloperidol, associated names: Aloperidin, Haldol-Janssen, Serenase, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/02/2017, EC decision date: 28/04/2017, Last updated: 05/05/2017 -
List item
Referral: Losec
omeprazole, associated names: Antra, Logastric, Losec Forte, Mopral, Omeprazen, Omeprazole, AstraZeneca, Zoltum, Article 30 referrals
Status: European Commission final decision, opinion/position date: 20/01/2010, EC decision date: 10/06/2010, Last updated: 19/09/2011 -
List item
Referral: Etopophos
etoposide phosphate, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/04/2017, EC decision date: 26/06/2017, Last updated: 14/07/2017 -
List item
Referral: Sandostatin LAR and associated names
ocreotide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/06/2014, EC decision date: 26/06/2014, Last updated: 27/06/2014 -
List item
Referral: Glucophage/Glucophage Forte/Risidon/Dianben
metformin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/10/2000, EC decision date: 06/02/2001, Last updated: 07/02/2001 -
List item
Referral: Ecazide
captopril, hydrochlorothiazide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/04/2002, EC decision date: 22/08/2002, Last updated: 19/09/2002 -
List item
Referral: Corlentor and Procoralan
ivabradine, associated names: Corlentor and Procoralan, Article 20 procedures
Status: European Commission final decision, opinion/position date: 20/11/2014, EC decision date: 15/01/2015, Last updated: 16/02/2015 -
List item
Referral: Roaccutane
isotretinoin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/04/2003, EC decision date: 17/10/2003, Last updated: 02/12/2003 -
List item
Referral: Efexor
venlafaxine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/07/2008, EC decision date: 28/11/2008, Last updated: 18/12/2008 -
List item
Referral: Tritace
ramipril, Article 30 referrals
Status: European Commission final decision, opinion/position date: 18/12/2008, EC decision date: 06/03/2009, Last updated: 24/04/2009 -
List item
Referral: Flolan
epoprostenol, associated names: Epoprostenol, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/05/2012, EC decision date: 08/08/2012, Last updated: 14/09/2012 -
List item
Referral: Lopid
gemfibrozil, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/03/2004, EC decision date: 29/07/2004, Last updated: 18/08/2004 -
List item
Referral: Zinbryta
associated names: Zinbryta, Article 20 procedures
Status: European Commission final decision, EC decision date: 27/03/2018, Last updated: 11/07/2018 -
List item
Referral: Human papillomavirus vaccines - Cervarix, Gardasil, Gardasil 9, Silgard
bivalent HPV vaccine (types 16, 18), quadrivalent HPV vaccine (types 6, 11, 16, 18), 9-valent HPV vaccine (types 6, 11, 16, 18, 31, 33, 45, 52 and 58), associated names: Cervarix, Gardasil, Gardasil 9, Silgard, Article 20 procedures
Status: European Commission final decision, opinion/position date: 19/11/2015, EC decision date: 12/01/2016, Last updated: 20/01/2016 -
List item
Referral: Daivobet
calcipotriol, betamethasone, associated names: Dovobet, Article 30 referrals
Status: European Commission final decision, opinion/position date: 22/07/2010, EC decision date: 30/09/2010, Last updated: 26/04/2011 -
List item
Referral: Arimidex
anastrozole, Article 30 referrals
Status: European Commission final decision, opinion/position date: 17/03/2011, EC decision date: 18/05/2011, Last updated: 27/07/2011 -
List item
Referral: Zinbryta
daclizumab, associated names: Zinbryta, Article 20 procedures
Status: European Commission final decision, opinion/position date: 09/11/2017, EC decision date: 08/01/2018, Last updated: 12/01/2018 -
List item
Referral: Tredaptive, Pelzont and Trevaclyn
laropiprant, nicotinic acid, Article 20 procedures
Status: European Commission final decision, EC decision date: 22/03/2013, Last updated: 17/05/2013 -
List item
Referral: Protelos and Osseor
strontium ranelate, Article 20 procedures
Status: European Commission final decision, opinion/position date: 20/02/2014, EC decision date: 15/04/2014, Last updated: 18/09/2014 -
List item
Referral: Atacand Plus
candesartan, hydrochlorothiazide, associated names: Atacand Zid, Blopresid, Blopress Comp, Blopress Plus, CoKenzen, Hytacand, Parapres Plus, Ratacand Plus, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/06/2010, EC decision date: 16/09/2010, Last updated: 21/09/2011